NeuBase Therapeutics, Inc.
NBSE · NASDAQ
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34 | -$25 | -$17 | -$27 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$1 | $0 | $0 |
| Stock-Based Comp. | $3 | $4 | $5 | $9 |
| Change in WC | $0 | $0 | $0 | $1 |
| Other Non-Cash | $0 | $3 | $1 | $13 |
| Operating Cash Flow | -$29 | -$19 | -$11 | -$3 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | -$1 | $0 | -$0 |
| Inv. Purchases | -$15 | -$60 | $0 | $0 |
| Inv. Sales/Matur. | $15 | $60 | $0 | $0 |
| Other Inv. Act. | -$0 | -$0 | -$1 | -$0 |
| Investing Cash Flow | -$0 | -$3 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $43 | $33 | $13 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $42 | $33 | $14 |
| Financing Cash Flow | -$0 | $42 | $33 | $14 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$30 | $21 | $22 | $10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53 | $32 | $10 | $0 |
| End Cash | $23 | $53 | $32 | $10 |
| Free Cash Flow | -$29 | -$20 | -$11 | -$3 |